Atopic outcomes at 2 years in the CORAL cohort, born in COVID-19 lockdown

Sadhbh Hurley1,2, Ruth Franklin1, Naomi McCallion1,3

  • 1Paediatrics and Child Health, Royal College of Surgeons, Dublin, Ireland.

Insights

Infants born during COVID-19 lockdown experienced higher rates of atopic dermatitis but lower rates of food allergies. This suggests the altered early-life environment may influence allergic condition development.

Area of Science:

  • Immunology
  • Pediatrics
  • Epidemiology

Background:

  • The COVID-19 pandemic lockdown created a unique early-life environment for newborns.
  • This environment was characterized by reduced antibiotic exposure, increased breastfeeding, and fewer infections.
  • These factors may influence the development of allergic conditions in infants.

Purpose of the Study:

  • To investigate the incidence of allergic conditions in infants born during the COVID-19 lockdown.
  • To compare allergic outcomes in a lockdown cohort (CORAL study) with a pre-pandemic cohort (BASELINE).

Main Methods:

  • A longitudinal observational study followed 365 infants from birth to 2 years.
  • Infants underwent assessments at 6, 12, and 24 months, including skin prick testing and atopic dermatitis evaluation.
  • Data were compared with a pre-pandemic cohort.

Main Results:

  • Higher incidence of atopic dermatitis (AD) was observed in the CORAL cohort at 12 and 24 months compared to the BASELINE cohort.
  • Despite higher AD, food allergies (milk, peanut, egg) were less common in the CORAL group.
  • Aeroallergen sensitization and wheezing episodes increased between 12 and 24 months in the CORAL cohort.

Conclusions:

  • The lockdown environment, despite increasing AD, may protect against food allergies, potentially due to altered infant infections and early allergen introduction.
  • These findings challenge the traditional hygiene hypothesis by suggesting potential benefits from reduced microbial exposure.
  • The study highlights the complex interplay between early-life environment and allergic disease development.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
433
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K